Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00646308 · ClinicalTrials.gov registry record
Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 60
- Enrollment target
NCT00646308 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 60 participants.
The verdict
NCT00646308 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if patients with a history of nonsecreting pituitary adenomas with untreated GH deficient patients have profiles consistent with increased cardiovascular risk compared to patients without GH deficiency who have undergone similar surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00646308
The ClinicalTrials.gov registry entry for NCT00646308 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00646308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00646308 about?
NCT00646308 is a clinical study titled "Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas". The purpose of this study is to determine if patients with a history of nonsecreting pituitary adenomas with untreated GH deficient patients have profiles consistent with increased cardiovascular risk compared to patients without GH deficiency who have undergone similar surgery.
What is the current status of trial NCT00646308?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2008-03. Estimated completion is 2010-03.
Who is sponsoring clinical trial NCT00646308?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.